Editorial Commentary: Should Platelet-Rich Plasma Be the New Standard? Reframing Biologic Strategies for Knee Osteoarthritis.

Abstract

Knee osteoarthritis remains one of the most challenging conditions in nonoperative orthopaedics. While hyaluronic acid has long been established in our injectable algorithm, evidence is increasing that platelet-rich plasma (PRP) can offer superior and longer-lasting outcomes. Based on data emerging from high-quality, double-blinded, randomized trials, we may now recognize the superiority of PRP as an alternative to other biologic therapies as well. A reconsideration of the hierarchy of intra-articular treatments is necessary, and PRP should be placed at the top of the list.